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Introduction Rheumatoid Arthritis (RA) is a chronic relapsing immune-
inflammatory multisystem disease with predominant synovial proliferation
and destruction of articular cartilage. Patients with RA have a higher riskof
mortality related to increased risk of cardiovascular disease with atherogenic
lipid profile. In recent years, oxidative stress in RA patients has received
considerable attention and has been implicated as mediators of tissue damage
and cardio-vascular disease in patients with RA.
The aim of the present study was to assess the lipid profile and lipid per-
oxide products of patients with rheumatoid arthritis compared with healthy
controls.
Patients and Methods The study included 70 patients of rheumatoid
arthritis who met the American College of Rheumatology (ACR) criteria were
included in the study and were compared to 40 healthy volunteers subjects.
Patients suffering from diabetes mellitus, hypothyroidism, liver or kidney dis-
ease, Cushing’s syndrome, obesity, familiar dyslipidemia and those receiving
medications affecting lipid metabolism were excluded from the study. Blood
samples of controls and patients were collected at the time of presentation and
analyzed for lipid profile (total cholesterol (TC), low-density lipoprotein
(LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol) and tri-
glycerides (TG); malondialdehyde (MDA-marker of oxidative stress) and
Conjugated Diene (CD) of RA versus healthy subjects.
Results Patients exhibited higher serum levels of TC, LDL-C and TG,
whereas their serum HDLC levels were significantly lower compared to
controls. As a consequence, the atherogenic ratio of TC/HDL-C (3,67±0,83 vs
4,51±1,12; p<0,001) as well as that of TG/HDL-C (0,71±0,19 vs 2,00±0,37;
p<0,001), was significantly higher in RA patients compared to controls. The
plasma MDA levels(0,57±0,37 vs 0,8±0,20; p<0,001) , the erythrocyte MDA
levels(14,78±2,7 vs 22,54±4,25; p<0.001), as well as the plasma CD
(121,65±36,75 vs 141,85±50,8; p<0,05) and the erythrocyte CD (142,23±54,74
vs 224,64±73,21, p<0,001) were higher in the patient group than in the control
group.
Conclusion According to our results, patients with RA exhibited an athero-
genic lipid profile with increased levels of oxidative stress markers. This situ-
ation accelerates vascular risk in RA. The results suggest the necessity for
therapeutic co-administration of antioxidants along with conventional drugs to
such patients. However, due to the limited number of cases included in this
study, more studies may be required. 
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Background Dysfunctional iron storage and transport are common in
patients with chronic heart failure and associated with poor prognosis. Body
iron could contribute to the pathogenesis of coronary artery disease (CAD)
through its ability to induce oxidative stress. However, studies on the relation-
ship between iron metabolism and CAD have yielded conflicting results.
Patients and Methods From the obseRvatoire des Infarctus de Côte d’Or
(RICO) survey, 31 consecutive patients admitted in Intensive Care Unit for a
first AMI were included. Serum concentrations of iron, transferrin, ferritin, the
iron-regulatory hormone hepcidin and erythroferrone (a new hepcidin-regu-
lating hormone), transferrin saturation and total iron binding capacity were
assessed on admission. 
Results Mean age was 65±16 yrs, 61% were male, 51% had hypertension,
23% diabetes, 45% dyslipidemia and 32% were smokers. There was a trend
toward a higher serum hepcidin concentration in men (99.8 versus 56.3 ng/ml,
p=0.181). Heart rate on admission was negatively associated with an erythro-
ferrone concentration (r=–0.428, p=0.023). 
Haemoglobin level and hematocrit were positively correlated with erythro-
ferrone concentration (p=0.027 and p=0.021). 
Moreover, a lower serum transferrin concentration was found in patients
with heart failure on admission (1.93±0.16g/l, vs 2.32±0.42, p=0.001). 
Ferritin concentration was positively related with infarct size, as assessed
by Creatine Kinase peak (r=0.535, p=0.002) and there was a trend toward a
positive correlation with erythroferrone concentration (r=0.314, p=0.085). 
Conclusion Elucidating the metabolic circuits regulated by peptidic hor-
mones will provide valuable insights into complex networks governing iron
availability in acute myocardial infarction.
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Background O-GlcNAcylation, a post-translational modification, is the
end product of the hexosamine biosynthetic pathway (HBP). Recent studies
showed beneficial effects of its increase in acute pathologies, such as hemor-
rhagic shock. We postulated that increase in total protein OGlcNAcylation at
the early phase of septic shock, a systemic inflammation associated with a car-
diovascular dysfunction, could improve cardiovascular function and reduce
mortality.
Methods To induce an endotoxemic shock, rats (n=6-8) received iv either
lipopolysaccharide (LPS, 5mg/kg) or saline (CTRL). After 1 h, fluid resusci-
tation (FR,15mL/kg of colloid, iv) was associated or not with HBP substrate:
glucosamine (GlcN, 180mg/kg) or an O-GlcNAcase inhibitor (NButGT,
10mg/kg). Two hours later, echography and mean arterial pressure (MAP)
evaluation were performed; blood samples and heart were then collected to
evaluate biological parameters (lactate, troponin T) and total O-GlcNAcyla-
tion by western-blot. 
Results In vivo studies showed an hypotension in LPS restored by FR and
treatments (MAP: CTRL 87±1, LPS 73±5*, LPS-FR 93±6#, NButGT 83±5,
GlcN 92±4mmHg, *: p<0.01 vs CTRL, #: p<0.01 vs LPS) and a systolic dys-
function in LPS with a trend toward an improvement by NButGT and GlcN
(ejection fraction: CTRL 80±3, LPS 66±3*, LPS-FR 69±2, NButGT 74±2,
GlcN 75±2%, *: p<0.01 vs CTRL). NButGT and GlcN efficiently increased
total O-GlcNAc (200 and 300% respectively vs LPS-FR). This effect was
associated with a reduced cardiomyocyte insult and tissue dysoxia. 
Conclusions At the early phase of septic shock NButGT and GlcN induce
an increase in cardiac O-GlcNAcylation leading to improve tissue oxygenation
and to reduce cardiac injury. These treatments trend to increase the cardiovas-
cular function. Yet, coming studies will evaluate the effect of NButGT and
GlcN on mortality.
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